Allergic diseases comprise a variety of conditions including allergic rhinitis, allergic asthma, atopic dermatitis, contact allergies, and food allergies.
Urticaria can also occur either as an allergic or nonallergic response.
The global prevalence of allergic diseases is up to 30% [ 6 weeks]), and “physical” according to European Academy of Allergology and Clinical Immunology/Global Allergy and Asthma European Network/European Dermatology Forum/World Allergy Organization (EAACI/GA(2)LEN/EDF/WAO) guidelines .
Allergic diseases pose a huge socioeconomic impact in terms of loss of productivity and effect on the patient’s quality of life.
In the European Union, an allergic person was estimated to have symptoms for an average of 51 working days per annum, hence affecting work performance and leading to absenteeism .
The duration of symptoms is expected to be higher in APAC due to the presence of perennial allergens.
A patient with persistent allergic rhinitis could be suffering throughout the year where symptoms could be mild to severe, thereby impairing daily activities.To increase awareness, allergy education programs targeted at GPs and patients may be beneficial.Updates to the existing international guidelines are suggested in APAC to reflect appropriate management for different patient profiles and varying symptoms of allergic rhinitis and urticaria.Allergic diseases are on the rise in many parts of the world, including the Asia–Pacific (APAC) region.Second-generation antihistamines are the first-line treatment option in the management of allergic rhinitis and urticaria.